VKTX position history
The shares of Viking Therapeutics (VKTX) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 310,067 shares, $5.8M, 0.02% of portfolio, New
- 2024 Q1: 493,259 shares, $40M, 0.11% of portfolio, Add +59.1%
- 2024 Q2: 502,819 shares, $27M, 0.08% of portfolio, Add +1.9%
- 2024 Q3: 474,644 shares, $30M, 0.08% of portfolio, Reduce −5.6%
- 2024 Q4: 385,472 shares, $16M, 0.04% of portfolio, Reduce −18.8%
- 2025 Q1: 402,207 shares, $9.7M, 0.03% of portfolio, Add +4.3%
- 2025 Q2: 126,737 shares, $3.4M, <0.01% of portfolio, Reduce −68.5%
- 2025 Q3: 126,737 shares, $3.3M, <0.01% of portfolio
- 2025 Q4: 125,827 shares, $4.4M, 0.01% of portfolio, Reduce −0.7%
- 2026 Q1: 125,486 shares, $4.1M, 0.01% of portfolio, Reduce −0.3%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|